Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Assunto da revista
Intervalo de ano de publicação
1.
Eur J Immunol ; 39(10): 2906-15, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19735075

RESUMO

TNF, lymphotoxin (LT)-alpha, LT-beta and LIGHT are members of a larger superfamily of TNF-related cytokines that can cross-utilize several receptors. Although LIGHT has been implicated in thymic development and function, the role of TNF and LT remains incompletely defined. To address this, we created a model of modest homeostatic overexpression of TNF/LT cytokines using the genomic human TNF/LT locus as a low copy number Tg. Strikingly, expression of Tg TNF/LT gene products led to profound early thymic atrophy characterized by decreased numbers of thymocytes and cortical thymic epithelial cells, partial block of thymocyte proliferation at double negative (DN) 1 stage, increased apoptosis of DN2 thymocytes and severe decline of T-cell numbers in the periphery. Results of backcrossing to TNFR1-, LTbetaR- or TNF/LT-deficient backgrounds and of reciprocal bone marrow transfers implicated both LT-alpha/LT-beta to LTbetaR and TNF/LT-alpha to TNFR1 signaling in accelerated thymus degeneration. We hypothesize that chronic infections can promote thymic atrophy by upregulating LT and TNF production.


Assuntos
Atrofia/genética , Expressão Gênica/genética , Linfotoxina-alfa/genética , Linfotoxina-beta/genética , Timo/patologia , Fator de Necrose Tumoral alfa/genética , Animais , Apoptose/genética , Apoptose/imunologia , Atrofia/patologia , Transplante de Medula Óssea , Contagem de Células , Proliferação de Células , Células Epiteliais/patologia , Dosagem de Genes/genética , Humanos , Queratina-8/metabolismo , Receptor beta de Linfotoxina/genética , Linfotoxina-alfa/metabolismo , Linfotoxina-beta/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Camundongos Transgênicos , Receptores Tipo I de Fatores de Necrose Tumoral/genética , Células-Tronco/patologia , Subpopulações de Linfócitos T/patologia , Linfócitos T/patologia , Timo/metabolismo , Fator de Necrose Tumoral alfa/metabolismo
2.
Mol Cell Biol ; 26(11): 4214-25, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-16705172

RESUMO

Lymphotoxin alpha (LTalpha) can exist in soluble form and exert tumor necrosis factor (TNF)-like activity through TNF receptors. Based on the phenotypes of knockout (KO) mice, the physiological functions of LTalpha and TNF are considered partly redundant, in particular, in supporting the microarchitecture of the spleen and in host defense. We exploited Cre-LoxP technology to generate a novel neomycin resistance gene (neo) cassette-free LTalpha-deficient mouse strain (neo-free LTalpha KO [LTalphaDelta/Delta]). Unlike the "conventional" LTalpha-/- mice, new LTalphaDelta/Delta animals were capable of producing normal levels of systemic TNF upon lipopolysaccharide (LPS) challenge and were susceptible to LPS/D-galactosamine (D-GalN) toxicity. Activated neutrophils, monocytes, and macrophages from LTalphaDelta/Delta mice expressed TNF normally at both the mRNA and protein levels as opposed to conventional LTalpha KO mice, which showed substantial decreases in TNF. Additionally, the spleens of the neo-free LTalpha KO mice displayed several features resembling those of LTbeta KO mice rather than conventional LTalpha KO animals. The phenotype of the new LTalphaDelta/Delta mice indicates that LTalpha plays a smaller role in lymphoid organ maintenance than previously thought and has no direct role in the regulation of TNF expression.


Assuntos
Linfotoxina-alfa/deficiência , Linfotoxina-alfa/imunologia , Fator de Necrose Tumoral alfa/metabolismo , Animais , Formação de Anticorpos/imunologia , Linfócitos T CD4-Positivos/citologia , Linfócitos T CD4-Positivos/imunologia , Adjuvante de Freund/imunologia , Imunidade Inata/imunologia , Lipopolissacarídeos/imunologia , Tecido Linfoide/imunologia , Linfotoxina-alfa/genética , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , Células Mieloides/imunologia , Neomicina , Ovalbumina/imunologia , Baço/citologia , Fator de Necrose Tumoral alfa/biossíntese
3.
Exp Hematol ; 33(11): 1348-56, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16263419

RESUMO

OBJECTIVES: The effects of TNF deficiency on myelopoiesis were evaluated in long-term (LTBMC) and short-term bone marrow cultures (STBMC) and compared to hematopoietic activity in vivo in TNF-deficient mice. METHODS: LTBMC and STBMC were established from bone marrow of TNF-deficient mice in the presence or absence of soluble TNF. Total cell production was measured over time, as well as the number of colony-forming units in culture (CFU-C). Morphology of nonadherent (NA) cells in LTBMC was assessed after 10 weeks. Bone marrow cells (BMC) and peripheral blood (PB) cells were used to determine lineage distribution within the hematopoietic system. BMC were sorted to obtain Lin(-)c-kit(+)Sca-1- and Lin(-)c-kit(+)Sca-1+ cells, which were plated in semisolid media to determine CFU-C numbers or injected into irradiated recipients to determine colony formation in the spleen (CFU-S). RESULTS: TNF-deficient LTBMC and STBMC show increased proliferative capacity, which can be inhibited by exogenous TNF to wild-type levels. Morphological analysis of NA cells from TNF-deficient LTBMC revealed increased numbers of cells at early stages of granulocytic differentiation (myeloblasts/promyelocytes) paralleled by a sharp decrease in the number of terminally differentiated polymorphonuclear neutrophils. Slightly elevated numbers of leukocytes, mainly neutrophils, were detected in PB of TNF-deficient mice. In bone marrow of TNF-deficient mice a significant increase in the number of both CFU-GM within Lin(-)c-kit(+)Sca-1- population and CFU-S within Lin(-)c-kit(+)Sca-1+ population was observed. CONCLUSIONS: TNF has inhibitory effects on granulocyte-macrophage progenitors in vitro and on committed and primitive hematopoietic progenitors in vivo. However, in adult organism TNF deficiency is mostly compensated and controlled.


Assuntos
Hematopoese/efeitos dos fármacos , Células-Tronco Hematopoéticas/citologia , Células-Tronco Multipotentes/citologia , Fator de Necrose Tumoral alfa/farmacologia , Fatores Etários , Animais , Contagem de Células , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Granulócitos/citologia , Granulócitos/efeitos dos fármacos , Transplante de Células-Tronco Hematopoéticas , Camundongos , Camundongos Knockout , Baço/citologia , Fator de Necrose Tumoral alfa/deficiência
4.
Immunity ; 22(1): 93-104, 2005 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-15664162

RESUMO

Tumor necrosis factor (TNF, TNFalpha) is implicated in various pathophysiological processes and can be either protective, as in host defense, or deleterious, as in autoimmunity or toxic shock. To uncover the in vivo functions of TNF produced by different cell types, we generated mice with TNF ablation targeted to various leukocyte subsets. Systemic TNF in response to lipopolysaccharide was produced mainly by macrophages and neutrophils. This source of TNF was indispensable for resistance to an intracellular pathogen, Listeria, whereas T-cell-derived TNF was important for protection against high bacterial load. Additionally, both T-cell-derived TNF and macrophage-derived TNF had critical and nonredundant functions in the promotion of autoimmune hepatitis. Our data suggest that T-cell-specific TNF ablation may provide a therapeutic advantage over systemic blockade.


Assuntos
Macrófagos/metabolismo , Neutrófilos/metabolismo , Linfócitos T/metabolismo , Fatores de Necrose Tumoral/fisiologia , Animais , Doenças Autoimunes/imunologia , Doenças Autoimunes/metabolismo , Comunicação Celular , Cruzamentos Genéticos , Deleção de Genes , Vetores Genéticos , Listeria/patogenicidade , Fígado/imunologia , Fígado/patologia , Camundongos , Camundongos Transgênicos , Sensibilidade e Especificidade , Linfócitos T/imunologia , Fatores de Necrose Tumoral/imunologia , Fatores de Necrose Tumoral/metabolismo
5.
Eur J Immunol ; 35(5): 1592-600, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15832287

RESUMO

We generated a novel tumor necrosis factor (TNF) null mutation using Cre-loxP technology. Mice homozygous for this mutation differ from their "conventional" counterparts; in particular, they completely lack Peyer's patches (PP) but retain all lymph nodes. Our analysis of these novel TNF-knockout mice supports the previously disputed notion of the involvement of TNF-TNFR1 signaling in PP organogenesis. Availability of TNF-knockout strains both with and without PP enables more definitive studies concerning the roles of TNF and PP in various immune functions and disease conditions. Here, we report that systemic ablation of TNF, but not the presence of PP per se, is critical for protection against intestinal Listeria infection in mice.


Assuntos
Camundongos Knockout/imunologia , Nódulos Linfáticos Agregados/imunologia , Fator de Necrose Tumoral alfa/deficiência , Fator de Necrose Tumoral alfa/genética , Animais , Citometria de Fluxo , Hematopoese/imunologia , Imuno-Histoquímica , Listeriose/imunologia , Camundongos , Camundongos Knockout/genética , Mutação , Nódulos Linfáticos Agregados/patologia , Fator de Necrose Tumoral alfa/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA